Genmab A/S (GNMSF) Cash & Current Investments (2018 - 2026)

Genmab A (GNMSF) has 7 years of Cash & Current Investments data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Cash & Current Investments fell 10.48% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (down 10.48% YoY) and the FY2025 annual result came in at $1.7 billion, down 41.94% from the prior year.
• Cash & Current Investments eased to $1.5 billion in Q1 2026, from $1.7 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $2.9 billion in Q2 2025 to a low of $43.0 million in Q3 2024.
• A 4-year average of $1.4 billion and a median of $1.6 billion in 2025 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 42.14% — and 2025, when it jumped 4320.93%.
• Tracing GNMSF's Cash & Current Investments over 4 years: stood at $2.4 billion in 2023, then sank by 42.14% to $1.4 billion in 2024, then rose by 23.29% to $1.7 billion in 2025, then decreased by 11.31% to $1.5 billion in 2026.
• The last three Cash & Current Investments figures came in at $1.5 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.